Medical News

RSS

Radiation primes the immune system to attack lung tumors resistant to immunotherapy

By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to the treatment, leading to positive outcomes for patients, according to new research by investigators at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Netherlands Cancer Institute.

22 Jul 2025

New insights into tick immune response could help prevent deadly virus transmission

Severe Fever with Thrombocytopenia syndrome virus (SFTSV) is a severe haemorrhagic fever virus transmitted by tick to animal and humans. Discovered in 2009, the virus is found in South-East Asian countries and has a fatality rate of up to 40%.

22 Jul 2025

New antibody therapy offers hope for fragile patients with Fanconi anemia

An antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic busulfan chemotherapy or radiation, a phase 1 clinical trial has shown.

22 Jul 2025

Understanding sleep patterns across lifespan through mathematics and biology

Wonder why babies nap on some days but not on others? Or why older people wake up earlier? Mathematical modelling of sleep regulation provides some surprising answers to these and other questions, according to a new study from the University of Surrey.

22 Jul 2025

Are 5 million nondisabled Medicaid recipients watching TV all day? That’s unsupported

Republicans defended the GOP megabill's Medicaid changes as targeting a group of people they believe shouldn't qualify: people who can work but instead choose to stay home and chill.

22 Jul 2025

Amid PFAS fallout, a Maine doctor navigates medical risks with her patients

When Lawrence and Penny Higgins of Fairfield, Maine, first learned in 2020 that high levels of toxic chemicals called PFAS taint their home's well water, they wondered how their health might suffer.

22 Jul 2025

Extreme childhood obesity drives liver and diabetes risks

Extreme obesity in US youth has risen significantly, linked to higher rates of diabetes and liver complications, necessitating immediate public health action.

22 Jul 2025

PhoreMost demonstrates new approach to rationalize molecular glue drug discovery

PhoreMost Ltd., a next-generation targeted protein degradation (TPD) company progressing a pipeline of degrader therapeutics within oncology and inflammation, today announced the publication of a study demonstrating the capabilities of its high-throughput GlueSEEKER platform to accelerate the design and development of novel molecular glue degraders.

22 Jul 2025

Date vinegar lowers blood sugar and cholesterol in type 2 diabetes

This study reveals that red date vinegar intake improves blood glucose and lipid profiles in type 2 diabetes, indicating potential for metabolic risk reduction.

22 Jul 2025

Vegan diets support high-level training, but risks of muscle loss

Vegan diets may enhance performance in semi-professional soccer players, but attention to protein and nutrient intake is crucial for muscle preservation.

22 Jul 2025

Toti-N-Seq breakthrough enables universal and scalable single-cell profiling

The rapid advancement of single-cell and single-nucleus RNA sequencing (sc/snRNA-seq) has opened unprecedented windows into cellular diversity, yet existing methods for multiplexing samples struggle with scalability and accuracy.

22 Jul 2025

PFAS exposure may increase the risk of developing type 2 diabetes

Exposure to a class of synthetic chemicals known as per- and polyfluoroalkyl substances (PFAS)-often called "forever chemicals"-may increase the risk of developing type 2 diabetes, according to a new study led by Mount Sinai researchers.

22 Jul 2025

Weight regain observed in patients after ending obesity drug treatment

Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, finds a meta-analysis published in BMC Medicine.

22 Jul 2025

Gluten may not be the culprit for many people with irritable bowel syndrome

A new study from McMaster University researchers has found that many people with irritable bowel syndrome (IBS) who believe they are sensitive to gluten or wheat may not actually react to these ingredients.

22 Jul 2025

Optimal Group joins SciY

The SciY business today announced the integration of Optimal Industrial Technologies and Optimal Industrial Automation into the SciY Laboratory Digitalization Suite, creating a single, vendor-agnostic software and automation platform that connects molecular research and development, quality control labs, and full-scale biopharma and specialty chemicals manufacturing environments.

From SciY 22 Jul 2025

Uranium isotope in urine identified as early warning sign of kidney damage

A new study by researchers at Columbia University Mailman School of Public Health identified that uranium's isotopic composition can be used as a biomarker to noninvasively measure accumulation of uranium in the kidneys.

22 Jul 2025

Can probiotics boost athletic performance? Review reveals what works and what still needs proof

A new review in Frontiers in Nutrition synthesizes recent evidence on how probiotic supplementation may impact gut health, immunity, and performance in athletes across various sports.

22 Jul 2025

Lidocaine poisonings and deaths rise sharply in the U.S.

Poisonings and deaths linked to the use of the local anaesthetic lidocaine have nearly tripled in the US over the past decade, finds an analysis of National Poison Data System (NPDS) reports, published online in the journal Regional Anesthesia & Pain Medicine.

22 Jul 2025

New study reveals distinct form of diabetes in African youth

An international team of researchers has made a key discovery: many children and young adults in Sub-Saharan Africa diagnosed with type 1 diabetes (T1D) may have a different form of the disease - one not caused by the immune system, unlike classic T1D.

21 Jul 2025

Australian study uncovers first potential prophylactic treatment against HTLV-1

Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease that currently has no preventative treatments and no cure.

21 Jul 2025